Polyphenols: Key issues involved in chemoprevention of prostate cancer

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Cimino, Sebastiano ^a   Sortino, Giuseppe ^a   Favilla, Vincenzo ^a   Castelli, Tommaso ^a   Madonia, Massimo ^b   Sansalone, Salvatore ^c   Russo, Giorgio Ivan ^a   Morgia, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOPREVENTION; CURCUMIN; EPIGALLOCATECHIN-3-GALLATE; FUTURE STRATEGY; GENISTEIN; POLYPHENOLS; PRENEOPLASTIC LESIONS; PROSTATE CANCERS; RESVERATROL; SIDE EFFECT;

FATTY ACIDS; PHENOLS; TUMORS; UROLOGY;

DISEASES;

CURCUMIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; POLYPHENOL; QUERCETIN; RESVERATROL; ANTIOXIDANT; CATECHIN; DRUG DERIVATIVE; FLAVONOID; STILBENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CANCER INHIBITION; CANCER PREVENTION; CHEMOPROPHYLAXIS; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; NONHUMAN; PROSTATE CANCER; REVIEW; CHEMISTRY; MALE; PROSTATE TUMOR;

ANTIOXIDANTS; CATECHIN; CURCUMIN; FLAVONOIDS; GENISTEIN; HUMANS; MALE; POLYPHENOLS; PROSTATIC NEOPLASMS; QUERCETIN; STILBENES;

EID: 84862273439     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/632959     Document Type: Review

References (53)

1. van Poppel H., Tombal B., Chemoprevention of prostate cancerwith nutrients and supplements Cancer Management and Research 2011 3 1 91 100
2. Rittmaster R. S., Chemoprevention of prostate cancer Acta Oncologica 2011 50 supplement 1 127 136
3. lusarz A., Shenouda N. S., Sakla M. S., Drenkhahn S. K., Narula A. S., MacDonald R. S., Besch-Williford C. L., Lubahn D. B., Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer Cancer Research 2010 70 8 3382 3390
4. Thomasset S. C., Berry D. P., Garcea G., Marczylo T., Steward W. P., Gescher A. J., Dietary polyphenolic phytochemicalspromising cancer chemopreventive agents in humans? A review of their clinical properties International Journal of Cancer 2007 120 3 451 458 (Pubitemid 44969013)
5. Pandey M., Gupta S., Green tea and prostate cancer: from bench to clinic Frontiers in Bioscience 2009 1 13 25
6. Johnson J. J., Bailey H. H., Mukhtar H., Green tea polyphenols for prostate cancer chemoprevention: a translational perspective Phytomedicine 2010 17 1 3 13
7. Khan N., Adhami V. M., Mukhtar H., Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies Nutrition and Cancer 2009 61 6 836 841
8. Adhami V. M., Malik A., Zaman N., Sarfaraz S., Siddiqui I. A., Syed D. N., Afaq F., Pasha F. S., Saleem M., Mukhtar H., Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo Clinical Cancer Research 2007 13 5 1611 1619 (Pubitemid 46450454)
9. Siddiqui I. A., Zaman N., Aziz M. H., Reagan-Shaw S. R., Sarfaraz S., Adhami V. M., Ahmad N., Raisuddin S., Mukhtar H., Inhibition of CWR22R 1 tumor growth and PSA secretion in athymic nude mice by green and black teas Carcinogenesis 2006 27 4 833 839
10. Adhami V. M., Ahmad N., Mukhtar H., Molecular targets for green tea in prostate cancer prevention Journal of Nutrition 2003 133 7 2417S 2424S (Pubitemid 36828848)
11. Zhou J. R., Yu L., Zhong Y., Blackburn G. L., Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice Journal of Nutrition 2003 133 2 516 521 (Pubitemid 36172909)
12. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A., Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study Cancer Research 2006 66 2 1234 1240 (Pubitemid 43165995)
13. Kurahashi N., Sasazuki S., Iwasaki M., Inoue M., Green tea consumption and prostate cancer risk in Japanese men: a prospective study American Journal of Epidemiology 2008 167 1 71 77
14. Khan N., Adhami V. M., Mukhtar H., Apoptosis by dietary agents for prevention and treatment of prostate cancer Endocrine-Related Cancer 2010 17 1 R39 R52
15. Goel A., Aggarwal B. B., Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs Nutrition and Cancer 2010 62 7 919 930
16. Khan N., Afaq F., Mukhtar H., Cancer chemoprevention through dietary antioxidants: progress and promise Antioxidants and Redox Signaling 2008 10 3 475 510
17. Syed D. N., Khan N., Afaq F., Mukhtar H., Chemoprevention of prostate cancer through dietary agents: progress and promise Cancer Epidemiology Biomarkers and Prevention 2007 16 11 2193 2203 (Pubitemid 351196348)
18. Markowski M. C., Bowen C., Gelmann E. P., Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1 Cancer Research 2008 68 17 6896 6901
19. Mukhopadhyay A., Bueso-Ramos C., Chatterjee D., Pantazis P., Aggarwal B. B., Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines Oncogene 2001 20 52 7597 7609 (Pubitemid 33111860)
20. Chung L. C., Tsui K. H., Feng T. H., Lee S. L., Chang P. L., Juang H. H., Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells Molecular Nutrition Food Research 2011 55 11 1666 1676
21. Cabrespine-Faugeras A., Bayet-Robert M., Bay J. O., Chollet P., Barthomeuf C., Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment Nutrition and Cancer 2010 62 2 148 153
22. Choi B. H., Kim C. G., Lim Y., Shin S. Y, Lee Y. H., Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway Cancer Letters 2008 259 1 111 118 (Pubitemid 350235095)
23. Hour T. C., Chen J., Huang C. Y., Guan J. Y., Lu S. H., Pu Y. S., Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBP expressions and suppressing NF- B activation Prostate 2002 51 3 211 218 (Pubitemid 34492642)
24. Chendil D., Ranga R. S., Meigooni D., Sathishkumar S., Ahmed M. M., Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3 Oncogene 2004 23 8 1599 1607 (Pubitemid 38406523)
25. Hong J. H., Ahn K. S., Bae E., Jeon S. S., Choi H. Y., The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo Prostate Cancer and Prostatic Diseases 2006 9 2 147 152 (Pubitemid 43970963)
26. Sharma R. A., McLelland H. R., Hill K. A., Ireson C. R., Euden S. A., Manson M. M., Pirmohamed M., Marnett L. J., Gescher A. J., Steward W. P., Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer Clinical Cancer Research 2001 7 7 1894 1900 (Pubitemid 32994823)
27. Chen A. L., Hsu C. H., Lin J. K., Hsu M. M., Ho Y. F., She T. S., Ko J. Y., Lin J. T., Lin B. R., Wu M. S., Yu H. S., Jee S. H., Chen G. S., Chen T. M., Chen C. A., Lai M. K., Pu Y. S., Pan M. H., Wang Y. J., Tsai C. C., Hsieh C. Y., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Research 2001 21 4 2895 2900
28. Sharma R. A., Euden S. A., Platton S. L., Cooke D. N., Shafayat A., Hewitt H. R., Marczylo T. H., Morgan B., Hemingway D., Plummer S. M., Pirmohamed M., Gescher A. J., Steward W. P., Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clinical Cancer Research 2004 10 20 6847 6854 (Pubitemid 39383033)
29. Ratan H. L., Steward W. P., Gescher A. J., Mellon J. K., Resveratrola prostate cancer chemopreventive agent? Urologic Oncology 2002 7 6 223 227
30. Shih A., Zhang S., Cao H. J., Boswell S., Wu Y. H., Tang H. Y., Lennartz M. R., Davis F. B., Davis P. J., Lin H. Y., Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protien kinase C- Molecular Cancer Therapeutics 2004 3 11 1355 1363 (Pubitemid 39562580)
31. Tang S. N., Singh C., Nall D., Meeker D., Shankar S., Srivastava R. K., The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition Journal of Molecular Signaling 2010 5, article 14
32. Lee D. H., Szczepanski M., Lee Y. J., Role of Bax in quercetin-induced apoptosis in human prostate cancer cells Biochemical Pharmacology 2008 75 12 2345 2355
33. Vijayababu M. R., Kanagaraj P., Arunkumar A., Ilangovan R., Aruldhas M. M., Arunakaran J., Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression Journal of Cancer Research and Clinical Oncology 2005 131 11 765 771 (Pubitemid 41577954)
34. Vijayababu M. R., Arunkumar A., Kanagaraj P., Venkataraman P., Krishnamoorthy G., Arunakaran J., Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3) Molecular and Cellular Biochemistry 2006 287 1-2 109 116 (Pubitemid 44057398)
35. Yuan H., Young C. Y. F., Tian Y., Liu Z., Zhang M., Lou H., Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells Molecular and Cellular Biochemistry 2010 339 1-2 253 262
36. McCann S. E., Ambrosone C. B., Moysich K. B., Brasure J., Marshall J. R., Freudenheim J. L., Wilkinson G. S., Graham S., Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in Western New York Nutrition and Cancer 2005 53 1 33 41 (Pubitemid 43068551)
37. Zhao R., Xiang N., Domann F. E., Zhong W., Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells Nutrition and Cancer 2009 61 3 397 407
38. Perabo F. G. E., Von Lw E. C., Ellinger J., von Rcker A., Mller S. C., Bastian P. J., Soy isoflavone genistein in prevention and treatment of prostate cancer Prostate Cancer and Prostatic Diseases 2008 11 1 6 12 (Pubitemid 351250324)
39. Lakshman M., Xu L., Ananthanarayanan V., Cooper J., Takimoto C. H., Helenowski I., Pelling J. C., Bergan R. C., Dietary genistein inhibits metastasis of human prostate cancer in mice Cancer Research 2008 68 6 2024 2032 (Pubitemid 351416590)
40. Campos A. C. E., Molognoni F., Melo F. H. M., Galdieri L. C., Carneiro C. R. W., D'Almeida V., Correa M., Jasiulionis M. G., Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation Neoplasia 2007 9 12 1111 1121 (Pubitemid 350255359)
41. Lazarevic B., Boezelijn G., Diep L. M., Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial Nutrition and Cancer 2011 63 6 889 898
42. Banerjee S., Li Y., Wang Z., Sarkar F. H., Multi-targeted therapy of cancer by genistein Cancer Letters 2008 269 2 226 242
43. Athar M., Back J. H., Tang X., Kim K. H., Kopelovich L., Bickers D. R., Kim A. L., Resveratrol: a review of preclinical studies for human cancer prevention Toxicology and Applied Pharmacology 2007 224 3 274 283 (Pubitemid 47575677)
44. Gupta S. C., Kannappan R., Reuter S., Kim J. H., Aggarwal B. B., Chemosensitization of tumors by resveratrol Annals of the New York Academy of Sciences 2011 1215 1 150 160
45. Athar M., Back J. H., Kopelovich L., Bickers D. R., Kim A. L., Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms Archives of Biochemistry and Biophysics 2009 486 2 95 102
46. Goldberg D. M., Yan J., Soleas G. J., Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clinical Biochemistry 2003 36 1 79 87 (Pubitemid 36126394)
47. Vijayababu M. R., Kanagaraj P., Arunkumar A., Ilangovan R., Dharmarajan A., Arunakaran J., Quercetin induces p53-independent apoptosis in human prostate cancer cells by modulating Bcl-2-related proteins: a possible mediation by IGFBP-3 Oncology Research 2006 16 2 67 74
48. Ziech D., Franco R., Pappa A., Panayiotidis M. I., Reactive Oxygen Species (ROS)induced genetic and epigenetic alterations in human carcinogenesis Mutation Research 2011 711 1-2 167 173
49. Donkena K. V., Young C. Y., Tindall D. J., Oxidative stress and DNA methylation in prostate cancer Obstetrics and Gynecology International 2010 2010 14
50. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A., Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 2009 30 7 1073 1081
51. Wellen K. E., Thompson C. B., Cellular metabolic stress: considering how cells respond to nutrient excess Molecular Cell 2010 40 2 323 332
52. Suzuki K., Koike H., Matsui H., Ono Y., Hasumi M., Nakazato H., Okugi H., Sekine Y., Oki K., Ito K., Yamamoto T., Fukabori Y., Kurokawa K., Yamanaka H., Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3 International Journal of Cancer 2002 99 6 846 852 (Pubitemid 34575703)
53. Harper C. E., Cook L. M., Patel B. B., Wang J., Eltoum I. A., Arabshahi A., Shirai T., Lamartiniere C. A., Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats Prostate 2009 69 15 1668 1682